Dosage Titration of Vancomycin

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-13003564

Enrollment

Unknown

Registered

2013-08-17

Start date

2013-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Interventions

Case series:Therapeutic Drug monitoring

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who receiving vancmycin therapy

Exclusion criteria

Exclusion criteria: Patients refuse.

Design outcomes

Primary

Measure	Time frame
Serum Drug concentration;	—

Secondary

Measure	Time frame
Serum Creatinine;	—

Countries

China

Contacts

Public ContactWu Dawei

Qilu Hospital of Shandong University

wdw.55@163.com+86 13791122767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026